Humana (NYSE: HUM) Earnings Q1 2011

 


View Humana's (NYSE: HUM) Q1 Earnings Report


Highlights:

  • Earnings per share of $1.86 for the first qurater of 2011, up from $1.52 in Q1 2010
  • First-quarter 2011 operational expenses were $8.7 million, a nine percent decrease over Q1 2010
  • Q1 revenues were $9.1 billion, increasing nearly 10 percent from the first quarter of 2010. The increase was primarily due a year-over-year increase in premiums and services in its Retail and Health and Well-Being Services segments. However, the company's Employer Group revenues declined
  • Q1 net income was $315 million, nearly 22 percent higher than Q1 2010
  • Consolidated benefit ratio was 83.8 percent in Q1 2011, a 30 basis point increase from Q1 2010, when the benefit ratio was 83.5 percent 
  • Added 875,000 new members to its health plans in the first quarter, across all business lines except individual policies. Human has 34 million members and expects to maintain this number throughout 2011. 
  • Full-year 2011 earnings expected to be in a range of $6.70 to $6.90 per share, compared to its previous estimate of $5.95 to $6.15

Notable quote: "It is reasonably possible that the Health Insurance Reform Legislation and related regulations, as well as future legislative changes, in the aggregate may have a material adverse effect on our results of operations, including restricting revenue, enrollment and premium growth in certain products and market segments, restricting our ability to expand into new markets, increasing our medical and administrative costs, lowering our Medicare payment rates and increasing our expenses associated with the non-deductible federal premium tax and other assessments; our financial position, including our ability to maintain the value of our goodwill; and our cash flows."

For more information:
- Read this 10-Q report filed with the SEC
- Check out Humana's current earnings estimates from CNN Money
Read this press release
- See how HUM is performing right now
- Humana's website: www.humana.com

Suggested Articles

Outpatient specialty drugs can be a lucrative income source for not-for-profit hospitals, but Washington presents some risks, Moody's says.

The growing role of data in our lives raises important questions about data access and ownership. Who rightfully owns the data?

Anthem posted $1.18 billion in third-quarter profit, an increase of 23% over the prior-year quarter.